- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Association between inflammatory potential of diet and bladder cancer risk:Results from three US prospective cohort studies.Bladder CancerApril 24, 2019
-
The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.Bladder CancerApril 24, 2019
-
Molecular characterization of neuroendocrine-like bladder cancer.Bladder CancerApril 24, 2019
-
Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy.Bladder CancerApril 23, 2019
-
Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer.Bladder CancerApril 23, 2019
-
The current role of circulating biomarkers in non-muscle invasive bladder cancer.Bladder CancerApril 23, 2019
-
An improved ileal conduit surgery for bladder cancer with fewer complications.Bladder CancerApril 22, 2019
-
Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer.Bladder CancerApril 22, 2019
-
Active surveillance for non-muscle invasive bladder cancer.Bladder CancerApril 22, 2019
-
SIU-ICUD consultation on bladder cancer: basic science.Bladder CancerApril 21, 2019
Beyond the Abstracts
-
Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation. - Beyond the AbstractBladder CancerMarch 28, 2019
-
Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer - Beyond the AbstractBladder CancerMarch 26, 2019
-
Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? - Beyond the AbstractBladder CancerFebruary 22, 2019
-
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy - Beyond the AbstractBladder CancerFebruary 22, 2019
-
The Development of Interferon-Based Gene Therapy for BCG Unresponsive Bladder Cancer: From Bench to Bedside – Beyond the AbstractBladder CancerFebruary 6, 2019
-
Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios - Beyond the AbstractBladder CancerJanuary 16, 2019
-
A risk-stratified Approach to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Implications for Patients Classified with Low-risk Disease - Beyond the AbstractBladder CancerJanuary 15, 2019
-
Molecular Footprints of Muscle-Invasive Bladder Cancer in Smoking and Nonsmoking Patients - Beyond the AbstractBladder CancerDecember 10, 2018
-
Transcriptomic and Protein Analysis of Small Cell Bladder Cancer Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target - Beyond the AbstractBladder CancerDecember 9, 2018
-
Implications of Micropapillary Urothelial Carcinoma Variant on Prognosis Following Radical Cystectomy: A Multi-Institutional Investigation – Beyond the AbstractBladder CancerDecember 9, 2018
E-Newsletters
Free Daily and Weekly newsletters offered by content of interest
The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.